Right Ventricular Failure
11
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.1%
1 terminated out of 11 trials
83.3%
-3.2% vs benchmark
9%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE
Mitigating Post-Op RV Dysfunction After LVAD Implantation
Effects of Negative Pressure Ventilation on Right Ventricular Function in Cardiological Patients
Reversal of Right Ventricular Steatosis in Pulmonary Hypertension
Right Ventricle Dysfunction in Patients Undergoing Lung Transplant
Significance of Impedance Cardiography and Early Repolarization Pattern in ECG in Congestive Heart Failure
CentriMag RVAS U.S. Post-approval Study Protocol
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients
Quantitative Assessment of RV Strain Using cMRI Following Catheter Intervention on PE
Right Ventricular Resynchronization Therapy